Arbutus Biopharma Corp. (ABUS)
4.12
-0.02
(-0.48%)
USD |
NASDAQ |
Jan 22, 13:16
Arbutus Biopharma Total Liabilities (Quarterly): 20.31M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Moderna, Inc. | 2.805B |
| Merck & Co., Inc. | 77.64B |
| Trevi Therapeutics, Inc. | 9.568M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
| Palatin Technologies, Inc. | 8.218M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 97.71M |
| Shareholders Equity (Quarterly) | 77.40M |
| Debt to Equity Ratio | 0.0595 |
| Current Ratio | 18.80 |
| Net Debt Paydown Yield | 0.07% |